Hormonal IUD (Mirena/Kyleena) and Diphenhydramine: What Women Need to Know

The Short Answer: No Meaningful Drug Interaction

Diphenhydramine does not meaningfully interact with a levonorgestrel-releasing intrauterine device. The IUD works locally, inside the uterine cavity, and releases levonorgestrel at approximately 20 mcg per day (Mirena) or 9 mcg per day (Kyleena). Systemic levonorgestrel levels from an IUD are far lower than those from oral contraceptives, which makes the drug-drug interaction picture quite different from what you might expect if you were comparing pill-based progestins with antihistamines.

Diphenhydramine, sold widely as Benadryl, is a first-generation antihistamine with strong anticholinergic and CNS-depressant properties. It is metabolized primarily by hepatic CYP2D6 and, to a lesser extent, CYP3A4. Levonorgestrel from an IUD reaches serum concentrations of roughly 150 to 200 pg/mL, which is too low to compete meaningfully at any shared enzyme pathway. The result: no pharmacokinetic interaction worth clinical concern.

Why This Question Gets Asked

Women searching this topic are often worried that an antihistamine might "cancel out" their birth control, as certain enzyme-inducing drugs (rifampin, carbamazepine, some antiretrovirals) can do with oral hormonal contraceptives. That fear does not apply here. The levonorgestrel IUD's mechanism is predominantly local: it thickens cervical mucus, suppresses endometrial proliferation, and reduces sperm motility within the uterine cavity. This local mechanism is not affected by changes in hepatic enzyme activity driven by diphenhydramine.

How Levonorgestrel IUDs Work: The Pharmacology That Matters

Understanding the interaction requires a short look at how each drug behaves in your body.

Levonorgestrel IUD Pharmacokinetics

Mirena (52 mg levonorgestrel) and Kyleena (19.5 mg levonorgestrel) both release hormone directly into the endometrial cavity. Peak serum levonorgestrel after Mirena insertion is approximately 206 pg/mL at six weeks, dropping to around 192 pg/mL at one year and continuing to decline. For Kyleena, serum concentrations are even lower, averaging around 93 pg/mL at three months. Compare that to a combined oral contraceptive pill, which delivers levonorgestrel at serum concentrations roughly ten times higher. The IUD's low systemic exposure is precisely why CYP enzyme-inducing drugs matter less for IUD users than for pill users.

Levonorgestrel is bound extensively to sex hormone-binding globulin (SHBG) and albumin in the circulation. It is hepatically cleared, but at IUD-delivered concentrations, the hepatic first-pass effect is largely irrelevant because the drug bypasses the gut entirely.

Diphenhydramine Pharmacokinetics

Diphenhydramine is taken orally and absorbed through the GI tract, reaching peak plasma concentrations in one to four hours, with a half-life of two to eight hours in healthy adults. It is a substrate of CYP2D6 with minor CYP3A4 involvement. Diphenhydramine is not a meaningful inhibitor or inducer of CYP3A4 at standard doses (25 to 50 mg), which is the enzyme most relevant to levonorgestrel clearance. At no point does diphenhydramine generate plasma concentrations that would shift levonorgestrel exposure in an IUD user.

The Real Concern: Overlapping Side Effects

The interaction that does exist is pharmacodynamic, not pharmacokinetic. Both diphenhydramine and progestins share certain physiological effects, and taking diphenhydramine on top of a hormonal IUD can amplify a few of them.

Sedation and CNS Depression

Diphenhydramine crosses the blood-brain barrier readily and causes significant drowsiness. In a 2020 review of over-the-counter sleep aids, diphenhydramine was associated with residual next-day sedation in approximately 25 percent of users at a 50 mg dose. Levonorgestrel itself does not cause sedation at IUD concentrations, so this is a one-sided concern: diphenhydramine adds sedation that is not counteracted or worsened by the IUD.

Where this matters more is if you are already taking other CNS-depressant medications, including sleep aids, benzodiazepines, opioids, or gabapentinoids. Adding diphenhydramine in that context raises your total CNS-depression burden.

Anticholinergic Effects

Diphenhydramine is one of the more potent anticholinergic agents available without a prescription. The American Geriatrics Society Beers Criteria specifically flags diphenhydramine for its anticholinergic burden in older adults, and while most IUD users are younger, perimenopausal women in their late forties may be using other anticholinergic medications (bladder medications, tricyclic antidepressants) where cumulative anticholinergic load becomes clinically relevant.

Anticholinergic effects from diphenhydramine include dry mouth, urinary retention, blurred vision, and constipation. Progesterone and progestins at higher doses can independently slow GI motility; at IUD concentrations, this effect is minimal, but it is worth noting if you are already prone to constipation.

Mood and Hormonal Sensitivity

Some women with a levonorgestrel IUD report mood changes, particularly in the first three to six months after insertion. A Danish registry study of over one million women found that hormonal contraceptive users had a statistically significant increase in antidepressant use, with progestin-only methods showing a relative risk of 1.4 compared with non-users. Diphenhydramine can cause paradoxical agitation or low mood in some women, particularly at higher doses or with repeated use. If you are already experiencing mood-related side effects from your IUD, using diphenhydramine regularly as a sleep aid could complicate the clinical picture.

Female-Specific Physiology: Life Stage Matters

The risk profile of diphenhydramine shifts at different reproductive life stages. Here is a stage-by-stage breakdown.

Reproductive Years (Ages 18 to 40)

For most women in this group, occasional diphenhydramine use for allergies, colds, or short-term sleep support poses no concern alongside a levonorgestrel IUD. The IUD's contraceptive efficacy remains intact. The key practical note: avoid driving or operating machinery for six to eight hours after a 50 mg dose. If you use diphenhydramine more than two to three nights per week, speak with your clinician. Chronic use of anticholinergics at younger ages is not well-studied in women specifically, and dependence on OTC sleep aids is worth addressing independently of the IUD question.

Trying to Conceive (After IUD Removal)

Once the IUD is removed, fertility typically returns quickly. Most women ovulate within the first cycle after Mirena removal. Diphenhydramine has been investigated in fertility contexts; some animal data suggest antihistamines may affect implantation, but human data are insufficient to draw conclusions. If you are actively trying to conceive after IUD removal, chronic daily diphenhydramine use is not recommended, and you should discuss allergy management alternatives with your clinician.

Perimenopause (Ages 40 to 55)

Mirena is commonly used in perimenopause for heavy menstrual bleeding and as the progestogen component of menopausal hormone therapy. ACOG Practice Bulletin 128 supports levonorgestrel IUD use for menorrhagia and endometrial protection in perimenopausal women. At this life stage, polypharmacy is more common. Perimenopausal women may already be taking gabapentin for hot flashes, SSRIs for mood, or bladder medications with anticholinergic properties. Adding diphenhydramine in this context increases the cumulative anticholinergic and sedation burden meaningfully. Sleep disruption is extremely common in perimenopause, which is why many women reach for Benadryl, but first-line treatments for perimenopausal insomnia include cognitive behavioral therapy for insomnia (CBT-I) and, where appropriate, hormone therapy, not chronic antihistamine use.

Postmenopause

Women beyond menopause do not typically have a levonorgestrel IUD for contraception, but Mirena is sometimes retained for endometrial protection during systemic estrogen therapy. Anticholinergic sensitivity increases with age, and postmenopausal women are at higher risk for the cognitive and urinary side effects of diphenhydramine. The 2023 Beers Criteria update reiterates avoidance of diphenhydramine as a sleep aid in adults 65 and older.

Pregnancy and Lactation Safety

This section is required for any drug article on WomanRx.

Pregnancy

Levonorgestrel IUD: Both Mirena and Kyleena are contraindicated in confirmed or suspected pregnancy. The FDA label for Mirena states the device should not be inserted in a pregnant woman, and if pregnancy occurs with the IUD in place, the device should be removed if the strings are visible. In the rare event of pregnancy with an IUD in situ, there is an increased risk of ectopic pregnancy, septic abortion, and preterm delivery. If you miss a period with an IUD in place, take a pregnancy test and contact your clinician.

Diphenhydramine: FDA Pregnancy Category B. Animal studies have not demonstrated fetal harm, and no adequate well-controlled human studies exist in pregnant women at therapeutic doses. Diphenhydramine is generally considered acceptable for short-term use in pregnancy for allergic symptoms or nausea (often combined with doxylamine in Unisom formulations). High doses near delivery have been associated with neonatal withdrawal symptoms and should be avoided in the third trimester where possible.

Lactation

Levonorgestrel IUD during breastfeeding: The levonorgestrel IUD is a preferred postpartum contraceptive option. The CDC Medical Eligibility Criteria for Contraceptive Use (US MEC) classifies levonorgestrel IUD as Category 1 (no restriction) for breastfeeding women after four weeks postpartum. Minimal levonorgestrel is transferred into breast milk, and studies have not found adverse effects on infant growth or lactation duration.

Diphenhydramine during breastfeeding: This is where caution is warranted. Diphenhydramine does transfer into breast milk in small amounts, and LactMed lists diphenhydramine as a drug that may reduce milk supply through its anticholinergic mechanism of reducing secretions. Infant sedation from antihistamine transfer in breast milk has been reported with first-generation antihistamines. If you need an antihistamine while breastfeeding, cetirizine (Zyrtec) or loratadine (Claritin) are preferred because they have lower anticholinergic profiles and less CNS penetration. One-time or occasional use of diphenhydramine while nursing is unlikely to cause harm, but routine use should be discussed with your provider.

Who This Combination Is Right For (and Who Should Be Careful)

Likely Fine With Occasional Use

• Women using Mirena or Kyleena for contraception with no other CNS-active medications who need a single-dose or short-course diphenhydramine for allergies or cold symptoms.
• Women in their reproductive years with no history of mood sensitivity to progestins who need occasional diphenhydramine for sleep on a flight or stressful night.
• Women using the levonorgestrel IUD for heavy menstrual bleeding management who have an acute allergic reaction and take one to two doses.

Use Caution or Seek an Alternative

• Perimenopausal women already taking gabapentin, a tricyclic antidepressant, a bladder anticholinergic, or a benzodiazepine. Cumulative anticholinergic burden is real and underrecognized.
• Postmenopausal women retaining a Mirena for endometrial protection who are over 65, given the Beers Criteria guidance.
• Breastfeeding women who need allergy relief. Choose cetirizine or loratadine instead.
• Women who notice mood-related side effects from their IUD and are considering diphenhydramine as a sleep aid. The combination may complicate mood assessment.
• Anyone with a personal or family history of urinary retention, narrow-angle glaucoma, or benign prostatic equivalent conditions (bladder outlet issues), where anticholinergic drugs carry added risk.

What the DDI Databases Say

Major drug interaction databases classify the Mirena/Kyleena plus diphenhydramine combination in the following way.

Drugs.com interaction checker lists no known direct interaction between levonorgestrel intrauterine system and diphenhydramine. Clinical Pharmacology (Elsevier) does not flag a pharmacokinetic interaction. The FDA labels for neither drug cross-reference the other. This absence of a listing in interaction databases is consistent with the pharmacology described above: no shared CYP pathway at clinically relevant concentrations, and the only pharmacodynamic overlap (anticholinergic load) is not unique to the IUD but applies to any hormonal or non-hormonal context.

Better Alternatives to Diphenhydramine for Common Reasons Women Take It

Many women reach for diphenhydramine not for allergies but for sleep. Here are clinically grounded alternatives that carry fewer concerns at each life stage.

For Allergies

• Cetirizine (Zyrtec) 10 mg daily: Second-generation antihistamine; minimal anticholinergic profile; compatible with breastfeeding.
• Loratadine (Claritin) 10 mg daily: Non-sedating; preferred during pregnancy for allergic rhinitis per most guidelines.
• Intranasal corticosteroids (fluticasone, budesonide): Minimal systemic absorption; first-line for allergic rhinitis in pregnancy and lactation per ACOG.

For Sleep

• CBT-I (Cognitive Behavioral Therapy for Insomnia): The American Academy of Sleep Medicine recommends CBT-I as the first-line treatment for chronic insomnia, outperforming pharmacotherapy for long-term outcomes.
• Melatonin 0.5 to 3 mg: Lower doses are equally effective as higher doses for sleep onset; considered safe short-term; data in pregnancy are limited, so use with caution.
• In perimenopause specifically: Hormone therapy addressing night sweats often resolves sleep disruption without the need for a sedative. The Menopause Society 2023 position statement supports hormone therapy as effective for sleep disruption driven by vasomotor symptoms.

Monitoring and Counseling Points

No laboratory monitoring is required when someone using a levonorgestrel IUD takes diphenhydramine. The clinical guidance is straightforward.

• Do not drive or operate heavy machinery within eight hours of a 50 mg diphenhydramine dose.
• Alcohol multiplies sedation from diphenhydramine; avoid combining them.
• If you plan to use diphenhydramine more than three nights per week for sleep, discuss this with your clinician. Rebound insomnia and tolerance develop quickly with first-generation antihistamines.
• If you are perimenopausal and taking multiple medications, ask your clinician to calculate your total anticholinergic burden using the Anticholinergic Cognitive Burden (ACB) scale. A score of 3 or above is associated with cognitive decline in long-term studies.
• IUD users do not need to use additional contraception when taking diphenhydramine. The IUD's effectiveness is not affected.

A Note on the Evidence Gap in Women

Women have been systematically underrepresented in pharmacokinetic and drug-drug interaction studies. Most of what we know about diphenhydramine's CYP2D6 metabolism comes from studies conducted predominantly in male subjects or mixed-sex cohorts where sex-stratified data are not reported. CYP2D6 activity differs by sex: women show on average 25 to 30 percent higher CYP2D6-mediated clearance than men in some studies, which means diphenhydramine may be cleared somewhat faster in women, potentially resulting in shorter duration of sedation. This is extrapolated from general CYP2D6 sex-difference literature, not from a dedicated levonorgestrel-IUD-plus-diphenhydramine trial, because no such trial exists.

The Danish cohort data on mood and progestin-only contraceptives referenced the work of Skovlund et al. (2016) and while it represents important signal data for women using hormonal contraception, the IUD subgroup findings need replication in prospective controlled studies. WomanRx will update this article as new primary data become available.